How should I manage a patient with blood cultures positive for Micrococcus species?

Management of Micrococcus Species Bacteremia

Micrococcus species isolated from blood cultures should be considered a likely contaminant unless multiple blood cultures are positive, and treatment should only be initiated after confirming clinical significance through repeat cultures and clinical assessment.

Initial Assessment and Diagnosis

The critical first step is determining whether the Micrococcus represents true bacteremia or contamination. Diagnosis of catheter-related bloodstream infection (CRBSI) due to Micrococcus species requires at least 2 positive blood culture results from different sites 1. This is essential because Micrococcus is a common skin commensal and frequently contaminates blood cultures 2.

Key Diagnostic Criteria:

• Multiple positive cultures: If only one blood culture set is positive and additional cultures (drawn within ±48 hours) are negative, the isolate should be considered a probable contaminant 2
• Clinical correlation: Review for risk factors including:
  • Presence of intravascular catheters (especially long-term central venous catheters)
  • Recent invasive procedures or surgeries 3
  • Immunocompromised state (malignancy, neutropenia) 3
  • Continuous infusion therapy (high incidence reported with epoprostenol for pulmonary hypertension) 1

When to Treat vs. Observe

Do NOT treat if:

• Only one blood culture set is positive
• Additional blood cultures within 48 hours are negative
• Patient is clinically stable without signs of sepsis
• No intravascular hardware present 1

DO treat if:

• Multiple blood cultures positive from different sites 1
• Patient has a short-term central venous catheter (CVC) - catheter removal is indicated 1
• Patient has a long-term catheter or implanted port with persistent bacteremia 1
• Clinical signs of infection persist (fever, elevated inflammatory markers)
• Immunocompromised patient with higher neutrophil percentage and elevated CRP 3

Treatment Approach

Catheter Management:

For patients with short-term CVCs: Remove the catheter immediately 1. This is the most critical intervention, as Micrococcus CRBSI is difficult to treat successfully without catheter removal 1.

For long-term catheters or implanted ports: Catheter removal is indicated unless there are no alternative intravascular access sites 1. Catheter retention attempts are generally not recommended for Micrococcus species due to high failure rates 1.

Antibiotic Selection:

Based on recent susceptibility data from a large case series 3:

• First-line empirical therapy: Cephalosporins (used in 59.2% of cases) or quinolones (21.4% of cases) are effective empirical choices
• Linezolid: Shows excellent activity (largest inhibition zone at 36mm) and should be considered for serious infections 3
• Vancomycin or teicoplanin: Reserve for potentially broadly drug-resistant strains 3
• Avoid erythromycin: Poorest activity (smallest inhibition zone at 15mm) 3

Duration of Therapy:

• With catheter removal: 5-7 days of systemic antibiotics for uncomplicated infection 1
• Without catheter removal (if attempted): 10-14 days with consideration of antibiotic lock therapy 1
• Complicated infection (persistent bacteremia >72 hours, metastatic infection): Follow principles for complicated bacteremia with 4-6 weeks of therapy 1

Follow-up and Monitoring

• Repeat blood cultures 2-4 days after initial positive cultures to document clearance of bacteremia 4
• If bacteremia persists beyond 72 hours despite appropriate therapy, suspect:
  • Suppurative thrombophlebitis (requires imaging with CT or ultrasound) 1
  • Endocarditis (consider echocardiography if risk factors present) 1
  • Undrained source requiring surgical intervention

Common Pitfalls to Avoid

1. Over-treating single positive cultures: The contamination rate for coagulase-negative Micrococcaceae is approximately 1.5% 5. Don't reflexively treat without confirming significance
2. Retaining catheters: Unlike coagulase-negative staphylococci, Micrococcus CRBSI rarely responds to catheter salvage attempts 1
3. Inadequate blood culture volume: Ensure 20-30 mL per culture set in adults to optimize pathogen detection 4, 6
4. Ignoring high-risk populations: Patients with malignancy (48.5% in one series) or recent invasive surgery (40.2%) warrant more aggressive evaluation 3

The quantitative rather than qualitative findings are most suitable for determining clinical significance 5 - multiple positive cultures with heavy growth are more likely to represent true infection than single cultures with light growth.